Surgery Archives - Page 3 of 7 - Cancer Therapy Advisor

Enhanced Recovery After Surgery Approach Evaluated as Postoperative Care for Early-Stage Gastric Cancer

By

January 30, 2020

ERAS clinical pathways typically involve early ambulation, and the early introduction of liquid and solid diets following surgery.

Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis.

ASCO GI 2020

Primary Tumor Resection Prior to Chemotherapy Does Not Improve OS in Patients With Synchronous Metastatic CRC

By

Susan Moench, PhD, PA-C

January 24, 2020

Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis.

Machine learning algorithm detected 7 types of cancer in liquid biopsy and identified tissue of disease origin.

General Oncology

US News & World Report’s “Crude” Tool for Cancer Outcome Differentiation

By

Leah Lawrence

November 21, 2019

The odds of postoperative complications were lower at top-ranked hospitals compared with non–top-ranked hospitals across a specific subset of cancer types.

A patient undergoes cancer-related surgery.

Gynecologic Cancer

Secondary Surgical Cytoreduction Not Superior in Ovarian Cancer

November 15, 2019

Addition of surgery prior to chemotherapy does not prolong overall survival in recurrent ovarian cancer.

Gastrointestinal Cancers

Enhanced Recovery After Surgery Program Leads to Less Opioid Use After Colorectal Cancer Surgery

By

Megan Garlapow, PhD

November 8, 2019

A retrospective chart review conducted after implementing an ERAS program demonstrated that improved patient education led to less use of opioids in the immediate postoperative period.

Evidence suggests that starting on systemic drug therapy immediately may be the best approach for so

General Oncology

Cancer Risk Halved With Bariatric Surgery-Linked Weight Loss

November 8, 2019

Hazard ratio 0.44 for incident cancer with loss of at least 20 to 35 versus <20 percent of total body weight.

Whether cryosurgery or cryoablation will prove a viable alternative to lumpectomy — the standard of

Skin Cancer

Bariatric Surgery Linked to Reduced Risk for Skin Cancer

November 1, 2019

For individuals with obesity, risk for skin cancer and melanoma significantly reduced with bariatric surgery.

A meta-analysis compared outcomes between the use of partial nephrectomy using a robotic surgical ap

Prostate Cancer

Investigating the Role of Salvage Lymph Node Dissection in Nonmetastatic CRPC

By

Susan Moench, PhD, PA-C

October 31, 2019

Traditionally, approaches to the management of patients with nonmetastatic CRPC following radical prostatectomy have been limited.

Gastrointestinal Cancers

Improving Patient Selection for Re-Resection of Metastatic Disease in Colorectal Cancer

By

Susan Moench, PhD, PA-C

October 30, 2019

In this study, the most common sites of recurrence following first resection of colorectal liver metastases were the liver (51%) followed by the lung (41%).

As post-transplant medications are used to reduce the body’s immune reaction to a foreign organ, the

ESMO 2019

Surgery May Blunt Response to Immune Checkpoint Inhibitor Therapy in Early-Stage NSCLC

By

Susan Moench, PhD, PA-C

September 28, 2019

Evidence of surgery-related immune impairment included decreases in the percentages of effector T cells and NK cells, and an increase in the percentage of MDS cells.